Patel N K, Wright J, Sabharwal S, Afsharpad A, Bajekal R
Department of Trauma and Orthopaedic Surgery, Barnet and Chase Farm NHS Trust, Barnet, Hertfordshire, UK.
Ann R Coll Surg Engl. 2014 Jan;96(1):67-72. doi: 10.1308/003588414X13824511649850.
Few studies have reported the outcome of hip resurfacing arthroplasty (HRA) with respect to implant characteristics from non-specialist centres. We report the survival, clinical and radiological outcomes of a single surgeon series of HRA with an average follow-up duration of five years.
All consecutive HRAs performed by a single surgeon between 2003 and 2011 at a district general hospital were retrospectively examined clinically and radiologically.
A total of 85 patients underwent 109 HRAs (58 male [53.2%] and 51 female patients [46.8%]) with a mean follow-up period of 62 months (range: 12-102 months). The median age was 57 years (range: 25-75 years). The mean acetabular and femoral head component sizes were 54 mm (range: 48-64 mm) and 48 mm (range: 42-58 mm) respectively with a mean acetabular inclination angle of 42.9° (range: 20-75°). The survival rate was 95% with five revisions due to aseptic loosening (n=3) and fracture (n=2): these were predominantly for female patients (n=4), with significantly smaller mean acetabular (51 mm, p=0.04) and femoral (44 mm, p=0.02) implant sizes. Furthermore, they had a higher mean acetabular inclination angle of 48.1° (p=0.74). The mean Oxford hip score was 43.8 (range: 25-48) and the mean University of California Los Angeles (UCLA) activity score was 6.8 (range: 3-10). Radiological findings included heterotopic ossification in 13 (11.9%), radiolucent lines in 6 (5.5%), femoral neck thinning in 2 (1.8%) and femoral neck notching in 5 patients (4.6%).
We have shown that HRA at a non-specialist centre has short to medium-term outcomes comparable with those at specialist centres. HRA therefore remains a viable option although vigilance is required in case selection and follow-up according to national guidance.
很少有研究报道非专科中心进行的髋关节表面置换术(HRA)在植入物特性方面的结果。我们报告了由一位外科医生进行的一系列HRA的生存率、临床和放射学结果,平均随访时间为五年。
对2003年至2011年期间一位外科医生在一家区综合医院进行的所有连续HRA进行回顾性临床和放射学检查。
共有85例患者接受了109次HRA(58例男性[53.2%]和51例女性患者[46.8%]),平均随访期为62个月(范围:12 - 102个月)。中位年龄为57岁(范围:25 - 75岁)。髋臼和股骨头假体的平均尺寸分别为54毫米(范围:48 - 64毫米)和48毫米(范围:42 - 58毫米),髋臼平均倾斜角度为42.9°(范围:20 - 75°)。生存率为95%,有5例因无菌性松动(n = 3)和骨折(n = 2)进行了翻修:这些主要发生在女性患者(n = 4)中,其髋臼(51毫米,p = 0.04)和股骨(44毫米,p = 0.02)假体平均尺寸明显更小。此外,她们的髋臼平均倾斜角度更高,为48.1°(p = 0.74)。牛津髋关节评分平均为43.8(范围:25 - 48),加利福尼亚大学洛杉矶分校(UCLA)活动评分平均为6.8(范围:3 - 10)。放射学检查结果包括13例(11.9%)出现异位骨化,6例(5.5%)出现透亮线,2例(1.8%)出现股骨颈变细,5例(4.6%)出现股骨颈切迹。
我们已经表明,非专科中心的HRA在短期至中期的结果与专科中心相当。因此,HRA仍然是一个可行的选择,尽管根据国家指南在病例选择和随访方面需要保持警惕。